Avantor, Inc. (NYSE:AVTR) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC trimmed its position in shares of Avantor, Inc. (NYSE:AVTR) by 3.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 216,744 shares of the company’s stock after selling 7,859 shares during the quarter. Yousif Capital Management LLC’s holdings in Avantor were worth $4,567,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. State Street Corp increased its holdings in Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after buying an additional 8,206,695 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Avantor by 653.0% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after purchasing an additional 5,354,678 shares in the last quarter. FMR LLC raised its holdings in Avantor by 557.2% in the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock worth $120,950,000 after purchasing an additional 3,963,912 shares during the period. Janus Henderson Group PLC boosted its position in Avantor by 18.2% during the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after purchasing an additional 2,719,615 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in shares of Avantor by 146.5% in the third quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock valued at $67,996,000 after buying an additional 1,562,018 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AVTR has been the topic of a number of recent analyst reports. Robert W. Baird decreased their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Barclays lifted their target price on shares of Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. UBS Group restated a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Raymond James lowered their price objective on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. Finally, Wells Fargo & Company cut their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, Avantor has a consensus rating of “Moderate Buy” and an average target price of $27.46.

Avantor Stock Performance

Shares of Avantor stock opened at $19.15 on Friday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The business’s 50 day moving average price is $21.76 and its 200 day moving average price is $23.46. The company has a market cap of $13.03 billion, a price-to-earnings ratio of 41.63, a PEG ratio of 3.97 and a beta of 1.28. Avantor, Inc. has a one year low of $19.08 and a one year high of $28.00.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 4.54% and a return on equity of 12.24%. During the same quarter in the previous year, the business posted $0.22 EPS. On average, research analysts predict that Avantor, Inc. will post 0.98 EPS for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.